Literature DB >> 9298219

Measurement of telomeric DNA content in human tissues.

J E Bryant1, K G Hutchings, R K Moyzis, J K Griffith.   

Abstract

Telomeres, nucleoprotein complexes at the ends of eukaryotic chromosomes, are 10-12 kbp in length in somatic cells, but as small as 1-2 kbp in rapidly growing cancer cells. Southern blot analysis is currently the standard method for the measurement of telomere length. However, accurate determinations are not possible when DNA is broken or scant. To avoid these problems, a slot blot assay that quantitates the relative content, instead of length, of telomere DNA was developed. The relative contents of telomere DNA determined by this slot blot assay were directly proportional to the relative lengths of telomere DNA determined in parallel by Southern blot analysis. Relative telomere DNA content could be measured in samples containing as little as 15 ng of total DNA. Relative telomere DNA content, but not length, also was unaffected by breakage of DNA into fragments 1 kbp or less in length.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298219     DOI: 10.2144/97233st05

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  14 in total

1.  Telomere measurement by quantitative PCR.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

2.  Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining.

Authors:  Alan K Meeker; Wesley R Gage; Jessica L Hicks; Inpakala Simon; Jonathan R Coffman; Elizabeth A Platz; Gerrun E March; Angelo M De Marzo
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

3.  Real-time quantitative PCR of telomere length.

Authors:  Marcel E Gil; Thérèsa L Coetzer
Journal:  Mol Biotechnol       Date:  2004-06       Impact factor: 2.695

Review 4.  Telomere length measurement-caveats and a critical assessment of the available technologies and tools.

Authors:  Geraldine Aubert; Mark Hills; Peter M Lansdorp
Journal:  Mutat Res       Date:  2011-06-12       Impact factor: 2.433

5.  Genomic instability demonstrates similarity between DCIS and invasive carcinomas.

Authors:  Christopher M Heaphy; Marco Bisoffi; Nancy E Joste; Kathy B Baumgartner; Richard N Baumgartner; Jeffrey K Griffith
Journal:  Breast Cancer Res Treat       Date:  2008-09-11       Impact factor: 4.872

6.  Telomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancer.

Authors:  Eric G Treat; Christopher M Heaphy; Larry W Massie; Marco Bisoffi; Anthony Y Smith; Michael S Davis; Jeffrey K Griffith
Journal:  Urology       Date:  2009-07-16       Impact factor: 2.649

7.  Measurement of telomere DNA content by dot blot analysis.

Authors:  Masayuki Kimura; Abraham Aviv
Journal:  Nucleic Acids Res       Date:  2011-04-27       Impact factor: 16.971

Review 8.  Telomere length and common disease: study design and analytical challenges.

Authors:  Jennifer H Barrett; Mark M Iles; Alison M Dunning; Karen A Pooley
Journal:  Hum Genet       Date:  2015-05-19       Impact factor: 4.132

9.  Potential clinical role of telomere length in human glioblastoma.

Authors:  D La Torre; M Aguennouz; A Conti; M Giusa; G Raffa; R V Abbritti; A Germano'; F F Angileri
Journal:  Transl Med UniSa       Date:  2011-10-17

10.  Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.

Authors:  Kimberly S Butler; William C Hines; Christopher M Heaphy; Jeffrey K Griffith
Journal:  Cancer Med       Date:  2012-07-24       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.